This Beaten-Down 8%-Yielding Dividend Stock Is Finally on the Road to Recovery
Medical Properties Trust's new tenants are paying steadily rising rental rates.
The company has a couple more catalysts ahead.
It offers a high-yielding dividend and substantial upside potential as its stock price recovers.
These 10 stocks could mint the next wave of millionaires ›
Medical Properties Trust (NYSE: MPW) has endured a rough couple of years. The hospital-focused real estate investment trust (REIT) has faced the bankruptcies of its two largest tenants. Their financial troubles occurred during a period when interest rates surged, making it challenging to refinance debt as it matured.
Shop Top Mortgage Rates
Your Path to Homeownership
A quicker path to financial freedom
Personalized rates in minutes
However, the healthcare REIT has gotten past this rough patch. As a result, it's now finally on the road to recovery, which was evident in its second-quarter results. That puts its roughly 8%-yielding dividend on a much more sustainable foundation, making the REIT an interesting option for those seeking income and upside potential.
New tenants are starting to contribute
Medical Properties Trust spent much of last year dealing with the bankruptcy of its former top tenant, Steward Health Care. The REIT was able to take back control of its real estate from Steward last September as part of the bankruptcy settlement. That allowed the hospital owner to transition the hospital operations to new tenants. It ultimately replaced Steward with five new tenants at 17 properties.
Those new tenants started paying rent this year under leases that steadily escalate rental rates over the next two years. The group collectively paid only $3.4 million in rent during the first quarter. That amount increased to $11 million in the second quarter as rental rates continued to escalate steadily. This represented 96% of the rent it billed to these tenants (it didn't collect $500,000 in rent from two facilities due to some start-up issues). Three of its tenants are already paying the fully ramped-up cash rate.
Rising rental income from these tenants, along with continued stability from most of its existing portfolio, enabled Medical Properties Trust to book a total of $240.4 million of revenue during the quarter. Meanwhile, the REIT reported $0.14 per share of normalized funds from operations (FFO) in the period. That easily supported its dividend payment of $0.08 per share.
The recovery should continue
Medical Properties Trust anticipates that rents from its new tenants will increase to $17 million in the third quarter. This number should continue rising. The REIT expects to reach the fully stabilized rate in October 2026, of around $160 million annualized (approximately $40 million per quarter). That drives its confidence that its annualized cash rent will exceed $1 billion by the end of next year.
"In summary, our transitional portfolio is quickly ramping performance and rent payments as expected, and our other tenants from around the world are delivering consistent performance, driven by healthy volume and cost trends," stated Rosa Hooper, senior VP of operations, on the second-quarter call. She continued, "Put simply, MPT's portfolio is well positioned to continue to generate significant cash flow and create value for shareholders moving forward."
More potential catalysts ahead
The company has several potential additional catalysts that could enhance its ability to grow shareholder value in the future. One is the final resolution with its other bankrupt tenant (Prospect Medical Holding). In March, the bankruptcy court approved a settlement between the REIT, Prospect, and other parties that will allow the bankrupt healthcare company to sell its hospital operations and the related real estate owned by Medical Properties Trust. As those sales occur, the REIT will receive funds that it can use to repay debt or invest in new income-generating assets.
Medical Properties Trust also continues to explore ways to grow earnings, reduce its cost of capital, and enhance its valuation. For example, it continues to own very valuable hospital real estate that it could monetize, potentially through joint venture transactions. Future moves could help unlock shareholder value by selling stakes in its properties at strong valuations and recycling the capital into new, higher-return investments. These moves could boost its share price and its ability to rebuild its dividend.
Healthy total return potential
Shares of Medical Properties Trust currently sit more than 80% below where they were in early 2022 before interest rates started rising, and its tenant issues began to worsen. That slump is why the company offers such a high dividend yield despite two deep cuts.
With its tenant and balance sheet issues now in the rearview mirror, the REIT's reset dividend is safe and could start rising in the future as its rental income increases. That growth, along with future moves to unlock shareholder value, could help drive a recovery in Medical Properties Trust's stock price. This combination of income and upside potential makes it a potentially very attractive investment opportunity these days.
Trump's Tariffs Could Create $1.5 Trillion AI Gold Rush
The Motley Fool's analysts are tracking a massive shift in U.S. tech. Over $1.5 trillion is already flowing into infrastructure, AI, and advanced manufacturing… and the number keeps climbing.
Following a major tariff policy shift, a new AI Gold Rush is taking shape, and we think .
It builds the tech infrastructure that Apple, OpenAI, and others suddenly can't live without. We just released a full write-up on this under-the-radar stock — and why now might be the exact moment to move.
Continue »
*Stock Advisor returns as of August 4, 2025
Matt DiLallo has positions in Medical Properties Trust. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
This Beaten-Down 8%-Yielding Dividend Stock Is Finally on the Road to Recovery was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
The White House just got another useless gold ornament.
Billionaire Apple CEO Tim Cook presented Donald Trump with a gaudy personalized gift boasting a 24-karat gold base as the tech giant woo'ed the president at the White House on Wednesday. Cook dropped in to the White House bearing his golden gift to announce the tech company's extra $100 billion investment in American manufacturing as the president still waves the threat of tariffs. The president started the press conference by calling Cook, 'One of the great and most esteemed business leaders and geniuses and innovators anywhere in the world.'
Yahoo
3 minutes ago
- Yahoo
Rate cuts could be weeks away. Here's how much history says stocks could rise as the Fed eases policy.
Investors expect the Fed to resume rate cuts next month. Historically, rate cuts have led to strong S&P 500 gains, but there have been exceptions. Here's what history says about how the market behaves once rate cuts start back up. After a weak few months of job growth, investors are banking on rate cuts from the Federal Reserve at their September meeting, and history shows cuts could be like rocket fuel for stocks in the months that follow. LPL Financial recently conducted an analysis of how stocks have performed from the first rate cut in a rate-reduction cycle until the eventual start of a new hiking cycle. On average, the S&P 500 has returned 30.3% during the nine periods when rates have been on the decline since 1974. The median return during those periods was 13.3%. Returns have been positive in six of those nine cycles. "Using history and prior Fed cutting cycles as a guide, some upside potential may remain for the second half of 2025," Jeff Buchbinder, LPL's chief equity strategist, said in the August 5 report. "But of course, past performance does not guarantee future results, and a new tariff regime not seen since the 1930s could slow earnings growth and fuel volatility." The largest market surges came in the lead up to the dot-com bubble, when the S&P 500 rose 161% from 1995 to 1999, the analysis showed. Other big gains included 62.8% from 1984 to 1993, and 38.2% from 2019 to 2021. But rate cuts aren't always a tailwind, especially during recessionary periods where the Fed acts too late. The market fell 23.5% during the 2007-2009 rate-cutting cycle, and from 2001-2004, the S&P 500 dropped 9.6%. This time around, Buchbinder said it's not a sure thing that rate cuts will be a boon for stocks, with ebullient investor sentiment having pushed up the market to new highs despite uncertainty remaining about the health of the economy. The market has also risen 12% already since the Fed's first cut of the cycle last September. "The delayed effects of trade policy are likely to weigh on the economy in the second half, leading to weaker labor market demand," Buchbinder wrote. "Recent market complacency toward trade policy and an economic narrative dependent upon strong economic data has caught our attention in recent weeks as a potential point of weakness." It's also not a guarantee the Fed continues to ease policy in the months ahead. Economists at Morgan Stanley and Bank of America both see the central bank keeping rates steady for the rest of 2025 despite CME FedWatch data showing investors pricing in 93.2% odds that the Fed cuts in next month. Given the apparent heightened levels of risk at the moment, Buchbinder said a conservative approach could be the best way forward in the near term. The firm likes growth stocks, large caps, and the financials and communication services sectors, he said. "Bottom line, investors may be well served by bracing for occasional bouts of volatility given how much optimism is currently reflected in equity prices," Buchbinder said. The firm's short-term asset allocation committee "advises against increasing portfolio risk beyond benchmark targets currently and continues to monitor tariff negotiations, economic data, earnings, the bond market, and various technical indicators to identify a potentially more attractive entry point to add equities on weakness," he added. Read the original article on Business Insider Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
3 minutes ago
- Yahoo
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test
Becton, Dickinson and Company (NYSE:BDX) is one of the . On July 31, Becton, Dickinson and Company (NYSE:BDX) announced that it submitted an application to the U.S. FDA for a new, at-home HPV test. The new HPV test focuses on patients to self-collect a sample at their home using a swab, the size of a Q-tip, simplifying lab processing. According to BD, this method also reports more high-risk strains of HPV compared to other tests on the market today. A person wearing a state-of-the-art medical device for nerve conduction tests. 'We envision a world where women are empowered with access and a choice for their HPV screening, whether it be in a routine visit at the doctor's office or the comfort and privacy of their own home via a self-collected sample. Cervical cancer and the loss of more than 4,000 women per year to this devastating disease is preventable, and we believe at-home testing is an important leap forward to our goal of eliminating this type of cancer,' said Nikos Pavlidis, president of BD Diagnostic Solutions. BD's new HPV test will include a state-of-the-art self-collection swab technology that also offers convenient mailing from home to the lab, supporting broader participation in cervical cancer screening programs. The self-collected swab requires no manual sample preparation by clinical laboratory technologists. This process will allow them to focus on higher-value work. Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that focuses on the development, manufacturing, and sale of various medical supplies, devices, diagnostic products, and laboratory equipment. While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
